Search Results - Shilei Yang

Immune Checkpoint Inhibitors Plus an Anti-VEGF Antibody as the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Network Meta-Analysis and Cost-Effectiveness Analys... by Lu Li, Shilei Yang, Yanwei Chen, Li Tian, Ying He, Bin Wu, Deshi Dong

Connect to this object online.

Naringin Interferes Doxorubicin-Induced Myocardial Injury by Promoting the Expression of ECHS1 by Zirui Zhao, Zirui Zhao, Zirui Zhao, Shilei Yang, Shilei Yang, Yawen Deng, Liang Wang, Yifen Zhang, Yifen Zhang, Zhenyu Feng, Han Li, Zhongchao Chi, Zhongchao Chi, Yunpeng Xie, Deshi Dong, Deshi Dong

Connect to this object online.

The value of second-line anti-HER2 therapy in metastatic HER-2 positive patients: a cost-effectiveness analysis in China by Lu Li, Shilei Yang, Fengqi Fang, Li Tian, Ying He, Jia Li, Yanwei Chen, Deshi Dong

Connect to this object online.

Corrigendum: The value of second-line anti-HER2 therapy in metastatic HER-2 positive patients: a cost-effectiveness analysis in China by Lu Li, Shilei Yang, Fengqi Fang, Li Tian, Ying He, Jia Li, Yanwei Chen, Deshi Dong

Connect to this object online.

Global trends and partial forecast of adverse effects of medical treatment from 1990 to 2019: an epidemiological analysis based on the global burden of disease study 2019 by Xin Kong, Xufeng Tao, Lu Li, Xinya Zhao, Jiaqi Ren, Shilei Yang, Xuyang Chen, Hong Xiang, Guoyu Wu, Yunming Li, Deshi Dong

Connect to this object online.

Piperacillin enhances the inhibitory effect of tazobactam on β-lactamase through inhibition of organic anion transporter 1/3 in rats by Shilei Yang, Zhihao Liu, Changyuan Wang, Shijie Wen, Qiang Meng, Xiaokui Huo, Huijun Sun, Xiaodong Ma, Jinyong Peng, Zhonggui He, Kexin Liu

Connect to this object online.